QuDoS

Views & Analysis

Case study: Ensuring safety by digitally linking prescriptio...

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

Views & Analysis

‘Listen to your patients’: the best MS care honoured at QuDo...

Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.

R&D

Allogeneic cell therapy isn’t dead, with Brian Culley

Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks